Acorda Therapeutics

20 Biotech Stocks That Hedge Funds Are Selling
Seeking Alpha
Sun, 12/11/11 - 02:40 pm
Nabi
Pacific Biosciences
Dendreon
Momenta
Enzon
Acorda Therapeutics
ShangPharma
Charles River Laboratories
Sangamo BioSciences
BioSpecifics Technologies
Jazz Pharmaceuticals
Amgen
Sinovac Biotech
ViroPharma
Vanda
Insmed
Transcept
Cadence Pharmaceuticals
PDL Biopharma
Chelsea Therapeutics
Relatively Low Operating Margin Detected in Shares of BioMarin Pharmaceutical in the Biotechnology Industry (BMRN, SUPG, ACOR, CPHD, GHDX)
Investor's Business Daily
Sun, 10/9/11 - 03:51 pm
Biomarin
Supergen
Acorda Therapeutics
Cepheid
Genomic Health
7 Possible Biotech Takeover Targets
Seeking Alpha
Sun, 09/18/11 - 12:02 pm
Human Genome Sciences
Vertex Pharmaceuticals
Lexicon Pharmaceuticals
Amarin
Exelixis
Dendreon
Acorda Therapeutics
10 Biotech Stocks Being Dumped By Big Money Managers
Seeking Alpha
Tue, 08/30/11 - 08:36 am
Acorda Therapeutics
Albany Molecular Research
Arena Pharmaceuticals
Dyax
Cephalon
Charles River Laboratories
Nektar
Questcor Pharmaceuticals
Vanda
QLT
3 Undervalued Biotechs With Buyout Potential
Seeking Alpha
Wed, 08/3/11 - 11:08 am
Biogen Idec
Abbott Laboratories
Elan
Adeona
Acorda Therapeutics
M&A
Acorda Therapeutics narrows 2nd quarter loss as Amprya sales, expenses climb
Yahoo/AP
Mon, 08/1/11 - 10:29 am
Acorda Therapeutics
earnings
10 Biotech Takeover/LBO Targets With Bullish Options Sentiment
Seeking Alpha
Thu, 07/21/11 - 12:21 pm
M&A
Chelsea Therapeutics
Amgen
Human Genome Sciences
Acorda Therapeutics
Celgene
Dendreon
InterMune
Biomarin
Alnylam
Exelixis
5 Biotech Drug-Launch Stocks to Watch
TheStreet.com
Mon, 07/18/11 - 10:03 am
Human Genome Sciences
Vertex Pharmaceuticals
Acorda Therapeutics
Dendreon
Avanir
lupus
Benlysta
Incivek
hepatitis C
MS
AMPYRA
Provenge
prostate cancer
Nuedexta
PBA
5 Biotech Takeover / LBO Targets With Bullish Short Trends
Seeking Alpha
Sat, 07/16/11 - 11:39 am
Exelixis
InterMune
Dendreon
Savient
Acorda Therapeutics
July Catalysts for Biotech and Drug Stocks
Minyanville
Tue, 07/5/11 - 09:58 am
Seattle Genetics
Bristol-Myers Squibb
JNJ
advisory panels
FDA
Transcept
AstraZeneca
GSK
Human Genome Sciences
Merck
Theravance
Amgen
Biogen Idec
Acorda Therapeutics
Acorda licenses rights to neurological candidate from Medtronic
Fri, 07/1/11 - 06:02 pm
Acorda Therapeutics
license
Medtronic
7 Rallying Biotech Stocks With Conservative Accounting Practices
Seeking Alpha
Fri, 07/1/11 - 09:56 am
Acorda Therapeutics
Incyte
Chelsea Therapeutics
Regeneron
Spectrum Pharmaceuticals
Jazz Pharmaceuticals
Neurocrine
Acorda Pushes Sales of MS Drug
Minyanville
Wed, 06/29/11 - 12:07 am
Acorda Therapeutics
MS
multiple sclerosis
AMPYRA
3 Ways to Play Biotech With Options
Motley Fool
Tue, 06/14/11 - 08:05 pm
Amarin
SIGA technologies
Acorda Therapeutics
Orexigen
Vivus
Analyst raises Acorda target as Ampyra sales grow
Yahoo/AP
Mon, 06/13/11 - 06:11 pm
AMPYRA
Acorda Therapeutics
MS
Biogen Idec
multiple sclerosis
7 Dirt-Cheap Takeover Targets in Biotech
Seeking Alpha
Fri, 06/3/11 - 10:44 am
M&A
Acorda Therapeutics
Antares
Alnylam
BioSante
Catalyst
Inhibitex
Keryx
The Big Winner of the EU Drug Approval Bonanza
Motley Fool
Sat, 05/21/11 - 11:05 am
Benlysta
Human Genome Sciences
Vibativ
Theravance
GSK
Victrelis
Merck
Xgeva
Amgen
Yervoy
Bristol-Myers Squibb
Fampyra
Acorda Therapeutics
Biogen Idec
Three Likely Biotech Acquisition Targets
CNBC
Mon, 04/18/11 - 04:57 pm
M&A
biotech
Human Genome Sciences
Acorda Therapeutics
Forest Labs
Acorda Posts Profit, Outlook
Yahoo/Zacks
Sat, 02/19/11 - 11:32 am
Acorda Therapeutics
Acorda, Biogen fall on EU drug rejection
Marketwatch
Fri, 01/21/11 - 10:13 am
Acorda Therapeutics
Europe
Biogen Idec
Fampyra
MS
multiple sclerosis

Pages